Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,898Revenue $M82.4Net Margin (%)-74.4Altman Z-Score12.2
Enterprise Value $M2,817EPS $-1.4Operating Margin %-68.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-74.4Higher ROA y-yY
Price/Book55.310-y EBITDA Growth Rate %--Quick Ratio5.7Cash flow > EarningsY
Price/Sales34.45-y EBITDA Growth Rate %--Current Ratio5.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-94.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACJoel Greenblatt 2015-09-30 Sold Out -0.01%$77.84 - $152.25
($130.63)
$ 64.61-51%Sold Out0
ANACJoel Greenblatt 2015-06-30 Buy 0.01%$52.69 - $79.09
($65.44)
$ 64.61-1%New holding13,741
ANACFirst Eagle Investment 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.35)
$ 64.611385%Sold Out0
ANACFirst Eagle Investment 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 64.611064%New holding92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sullivan Ryan TEVP and General Counsel 2016-04-29Sell3,125$66.33-1.28view
Hove Anders DDirector 2016-04-08Sell229,301$71.1-7.9view
BERNS PAUL LPresident and CEO 2016-03-22Sell37,500$60.318.57view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-03-02Sell9,000$63.862.54view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-19Sell20,000$95.41-31.37view
Zane LeeSVP and Chief Medical Officer 2016-01-15Sell1,466$89.57-26.9view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-04Sell855$112.28-41.68view
Sullivan Ryan TSr. VP and General Counsel 2016-01-04Sell733$111.78-41.42view
BERNS PAUL LPresident and CEO 2016-01-04Sell2,533$112.35-41.72view
Zane LeeSVP and Chief Medical Officer 2015-12-15Sell14,000$113.17-42.14view

Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Royce Smaller-Companies Growth Fund Annual Letter Mar 19 2016 
    Royce Funds Comments on Anacor Pharmaceuticals Oct 12 2015 
    Staying Diversified in the Pursuit of Sustainable Growth - Royce Funds Commentary Oct 12 2015 
    Royce Smaller-Companies Growth Fund Shareholder Letter Sep 20 2015 
    Panic-Proofing the Small Investor Aug 26 2015 
    Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 

    More From Other Websites
    Anacor Pharmaceuticals to Present at the Deutsche Bank 41st Annual Healthcare Conference May 02 2016
    Anacor Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ANAC-US : May... May 02 2016
    Anacor Pharmaceuticals to Present at the Deutsche Bank 41st Annual Healthcare Conference May 02 2016
    Large Cap Blue Chips Highlight Jefferies Top Growth Stocks to Buy Apr 27 2016
    ETF’s with exposure to Anacor Pharmaceuticals, Inc. : April 21, 2016 Apr 21 2016
    Anacor Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ANAC-US :... Apr 20 2016
    Top Biotech Picks Highlight Jefferies Growth Stocks to Buy Apr 12 2016
    Anacor Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ANAC) : April 8, 2016 Apr 08 2016
    Anacor Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ANAC-US :... Apr 07 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Apr 06 2016
    Anacor Pharmaceuticals: $250 Million in Convertible Senior Notes Apr 06 2016
    2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful Apr 05 2016
    The 52-Week Low Club for Friday Apr 01 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 01 2016
    Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $250 Million of 2.00% Convertible... Mar 31 2016
    Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $250 Million of 2.00% Convertible... Mar 31 2016
    Why Target, Movado, & Other Stocks Tumbled Today? Mar 31 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 30 2016
    Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $250 Million of Convertible Senior Notes... Mar 30 2016
    Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $250 Million of Convertible Senior Notes... Mar 30 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)